Role and Regulation of a Molecular Mimic in Histoplasma Pathogenesis
分子模拟物在组织胞浆菌发病机制中的作用和调节
基本信息
- 批准号:8415503
- 负责人:
- 金额:$ 22.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntifungal AgentsAntigen PresentationAntigen Presentation PathwayApplications GrantsAttentionBinding ProteinsBiological ModelsBiologyBlastomyces dermatitidisCD1 AntigensCREB-binding proteinCellsClimateCollectionComplement Factor HDNA SequenceDataDefectDevelopmentDiseaseFutureGene Expression RegulationGene ProteinsGenesGeographic DistributionGoalsHaploidyHistoplasmaHistoplasma capsulatumHistoplasmosisHomologous GeneHousingHumanHuman PathologyImmuneImmune responseImmunocompromised HostIn VitroInfectionInsertional MutagenesisLibrariesLipid BindingLipidsLocationLungLysosomesMammalsMembraneMoldsMolecularMolecular GeneticsMusNutrientOrganismPathogenesisPenicilliumPhagolysosomePhagosomesPhasePolysaccharidesProliferatingProtein FamilyProteinsRecording of previous eventsRegulationRegulator GenesResearchResolutionRespiratory Tract InfectionsRoleSaposinsSoilSolutionsSphingolipid Activator Protein-1SporothrixStructural GenesStructureStudy modelsSystemic diseaseTemperatureTestingTranscriptional RegulationVirulenceVirulence FactorsWorkYeastsZoonosesbasedesignfungusin vivoinhibitor/antagonistinterestintracellular parasitismmacrophagemembermutantnovelpathogenresearch studythree dimensional structuretool
项目摘要
DESCRIPTION (provided by applicant): Histoplasma capsulatum is one of the classic "dimorphic" fungal pathogens, undergoing a temperature-induced transition from a mold form that grows in soil to a yeast form that establishes infection in lung macrophages. All of the dimorphic fungi cause the most severe disease in immunocompromised patients, but they are primary pathogens that can cause serious problems in hosts lacking any demonstrable immune defect. The first genetically proven virulence factor of H. capsulatum was CBP, a yeast phase-specific secreted protein that is important for proliferation within macrophages in vitro and in vivo. Solving the three-dimensional structure of CBP revealed a surprising similarity to saposin B, a mammalian protein involved in membrane processing and antigen presentation. Although the structural homology is strongly suggestive that CBP is the first identified fungal member of the large and diverse saposin-like protein family, its precise mechanistic role in histoplasmosis remains unproven. This grant application is designed to evaluate whether CBP indeed functions as a saposin and to understand the basis for CBP1 phase-specific regulation: Specific Aim 1. Define the saposin-like function of CBP. The studies in this Aim will first test whether CBP functions like a saposin in terms of binding lipids, either fungal or mammalian, and will include a
structure-function analysis to determine which residues of CBP are involved. The potential role of CBP in CD1 antigen presentation, analogous to the function of saposin B, will also be explored. Specific Aim 2. Identify the genes involved in CBP1 transcriptional regulation. Insertional mutagenesis will be used to generate a library of mutants that will be screened for those that no longer regulate CBP1 normally. The most promising candidate regulatory genes will subsequently be used to identify coordinately regulated genes, potentially unraveling a network of genes related to CBP function or to other roles in pathogenesis.
描述(由申请方提供):荚膜组织胞浆菌是一种典型的“二型”真菌病原体,经历温度诱导的从土壤中生长的霉菌形式转变为在肺巨噬细胞中建立感染的酵母形式。所有的二型真菌引起免疫功能低下患者的最严重的疾病,但他们是主要的病原体,可以导致严重的问题,在主机缺乏任何明显的免疫缺陷。H. capsulatum是CBP,一种酵母相特异性分泌蛋白,其对于体外和体内巨噬细胞内的增殖是重要的。解决CBP的三维结构揭示了一个令人惊讶的相似性saposin B,一种哺乳动物蛋白参与膜加工和抗原呈递。虽然结构同源性强烈暗示CBP是大型和多样的鞘脂激活蛋白样蛋白家族的第一个确定的真菌成员,但其在组织胞浆菌病中的确切机制作用仍未得到证实。该资助申请旨在评估CBP是否确实作为saposin发挥作用,并了解CBP 1阶段特异性调节的基础:具体目标1。定义CBP的saposin样功能。本目标中的研究将首先测试CBP在结合脂质方面是否像saposin一样起作用,无论是真菌还是哺乳动物,并将包括一个
结构-功能分析以确定CBP的哪些残基参与。CBP在CD 1抗原呈递中的潜在作用,类似于saposin B的功能,也将被探索。具体目标2。识别参与CBP 1转录调控的基因。插入诱变将用于产生突变体文库,所述突变体文库将筛选不再正常调节CBP 1的突变体。最有前途的候选调控基因随后将被用来确定协调调节基因,可能解开CBP功能或发病机制中的其他角色相关的基因网络。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM E GOLDMAN其他文献
WILLIAM E GOLDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM E GOLDMAN', 18)}}的其他基金
The evolution of virulence in the fungal pathogen Histoplasma
真菌病原体组织胞浆菌毒力的进化
- 批准号:
10210742 - 财政年份:2021
- 资助金额:
$ 22.2万 - 项目类别:
Evaluating the Role of Neutrophils in the Progression of Pneumonic Plague
评估中性粒细胞在肺鼠疫进展中的作用
- 批准号:
9412118 - 财政年份:2017
- 资助金额:
$ 22.2万 - 项目类别:
Discovering Histoplasma factors required for initial macrophage interaction
发现初始巨噬细胞相互作用所需的组织胞浆菌因子
- 批准号:
9243585 - 财政年份:2016
- 资助金额:
$ 22.2万 - 项目类别:
Early Events in the Pathogenesis of Pneumonic Plague
肺鼠疫发病机制的早期事件
- 批准号:
8443017 - 财政年份:2013
- 资助金额:
$ 22.2万 - 项目类别:
Role and Regulation of a Molecular Mimic in Histoplasma Pathogenesis
分子模拟物在组织胞浆菌发病机制中的作用和调节
- 批准号:
8281120 - 财政年份:2012
- 资助金额:
$ 22.2万 - 项目类别:
Molecular Mechanisms of Histoplasma Pathogenesis
组织胞浆菌发病机制的分子机制
- 批准号:
8297410 - 财政年份:2011
- 资助金额:
$ 22.2万 - 项目类别:
ROLE OF CALCIUM-BINDING PROTEIN AND FUNCTION IN LUNG DISEASE
钙结合蛋白的作用及其在肺部疾病中的功能
- 批准号:
7953952 - 财政年份:2009
- 资助金额:
$ 22.2万 - 项目类别:
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 22.2万 - 项目类别:
Research Grant
Engineering microbial cell factories for production of improved polyene antifungal agents
工程微生物细胞工厂用于生产改进的多烯抗真菌剂
- 批准号:
2898887 - 财政年份:2023
- 资助金额:
$ 22.2万 - 项目类别:
Studentship
Morphological profiling for the development of antifungal agents
用于开发抗真菌药物的形态分析
- 批准号:
22H02216 - 财政年份:2022
- 资助金额:
$ 22.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An efficient approach to find therapeutically effective antifungal agents
寻找治疗有效的抗真菌药物的有效方法
- 批准号:
22K05337 - 财政年份:2022
- 资助金额:
$ 22.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating light-activated therapeutic compounds as antifungal agents.
研究光激活治疗化合物作为抗真菌剂。
- 批准号:
2753345 - 财政年份:2022
- 资助金额:
$ 22.2万 - 项目类别:
Studentship
Discovery of novel therapeutic agents for biliary tract and pancreatic cancer based on antifungal agents
基于抗真菌药物的胆道癌和胰腺癌新型治疗药物的发现
- 批准号:
20H03533 - 财政年份:2020
- 资助金额:
$ 22.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of antifungal agents that target essential protein kinases in A. fumigatus.
开发针对烟曲霉必需蛋白激酶的抗真菌剂。
- 批准号:
2456629 - 财政年份:2020
- 资助金额:
$ 22.2万 - 项目类别:
Studentship
Elucidation of tip growth factor of fungi and construction of screeing system for antifungal agents
真菌尖端生长因子的阐明及抗真菌药物筛选体系的构建
- 批准号:
19K05738 - 财政年份:2019
- 资助金额:
$ 22.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ambruticins: An inspiration to develop novel biocatalysts and antifungal agents
Ambruticins:开发新型生物催化剂和抗真菌剂的灵感
- 批准号:
2107517 - 财政年份:2018
- 资助金额:
$ 22.2万 - 项目类别:
Studentship